Skip to main content

Table 2 Rates of EGFR exon 21 mutation

From: Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

Patient no.

Cells number

Mutation rate

P-value

Long PFS group

0.021

 No.1

19

17 (89.5%)

 No.2

21

17 (81.0%)

 No.3

19

17 (89.5%)

 Total

59

51 (86.4%)

Short PFS group

 No.4

18

13 (72.2%)

 No.5

21

14 (66.7%)

 No.6

22

15 (68.2%)

 Total

61

42 (68.9%)